argenx SE (ARGX)
Euronext
Closed
Aug 24, 2026
Day's Range
858.4052 wk Range
568.40Overview - ARGX - argenx SE
Key Statistics
Valuation
Enterprise Value
43.80B
P/E (Trailing)
‪40.92‬
P/E (Forward)
‪29.44‬
PEG Ratio
‪29.44‬
Price / Sales (TTM)
‪10.55‬
Price / Book
‪7.83‬
EV / EBITDA
‪31.78‬
Profitability
Gross Margin
‪90.42%‬
Profit Margin
‪32.26%‬
Operating Margin
‪31.99%‬
Return on Assets
‪11.63%‬
Return on Equity
‪23.63%‬
Ownership
Shares Outstanding
62.53M
Float
62.42M
Held by Insiders
‪0.01%‬
Held by Institutions
‪48.04%‬
Price stats
Beta
‪-0.04‬
50-Day Avg
‪780.30‬
200-Day Avg
‪720.43‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪€ 887.76‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ARGX - argenx SE
Peers - ARGX - argenx SE
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
- ARGXEuronextargenx SE56.09BMarket Cap+34.59%52-week change40.93P/E (Trailing)‪32.26%‬Profit Margin
- AGNEuronextAegon Ltd.11.46BMarket Cap+12.61%52-week change12.99P/E (Trailing)‪8.01%‬Profit Margin
- ABVXEuronextAbivax SA8.88BMarket Cap+35.76%52-week change-21.08P/E (Trailing)‪0.00%‬Profit Margin
- ALVIOEuronextValerio Tx Corp.424.53MMarket Cap+92.38%52-week change—P/E (Trailing)‪-190.36%‬Profit Margin
- ALCLSEuronextCellectis S.A.289.01MMarket Cap+16.73%52-week change-4.28P/E (Trailing)‪-102.33%‬Profit Margin
- ALSENEuronextSensorion SA141.71MMarket Cap-24.00%52-week change-2.75P/E (Trailing)‪0.00%‬Profit Margin
- AVTXEuronextAvantium N.V.122.63MMarket Cap-176.42%52-week change-2.86P/E (Trailing)‪-154.30%‬Profit Margin
Profile Summary - ARGX - argenx SE
About
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
